Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Sunitinib Bioavailability on Toxicity and Treatment Efficacy in Patients Treated for Metastatic Renal Cancer

NCT03846128 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT03846128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03846128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Sunitinib Bioavailability on Toxicity and Treatment Efficacy in Patients Treated for Metastatic Renal Cancer
Lead sponsor
University Hospital, Rouen
Phase
Observational
Overall status
Terminated
Start date
June 3, 2019
Completion date
October 8, 2021
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic kidney cancer